You Position: Home > Paper
Meta-analysis of the efficacy of Ahmed glaucoma drainage valve implantation combined with anti-VEGF drugs in the treatment of neovascular glaucoma
( views:54, downloads:34 )
- Author:
- No author available
- Journal Title:
- International Eye Science
- Issue:
- 12
- DOI:
- 10.3980/j.issn.1672-5123.2022.12.17
- Key Word:
- 新生血管性青光眼(NVG);抗血管内皮生长因子(VEGF);雷珠单抗;贝伐单抗;Ahmed青光眼引流阀;Meta分析
Abstract： 目的:系统地评估Ahmed青光眼引流阀(AGV)植入联合玻璃体腔抗血管内皮生长因子(VEGF)药物注射术相对于单纯AGV植入术治疗新生血管性青光眼(NVG)的安全性和有效性.方法:计算机检索PubMed、Cochrane Library、美国科学引文索引数据库(SCI)、中国知网(CNKI)、万方数据库等.检索时间为建库起至2021-07-20关于AGV植入术联合抗VEGF药物治疗NVG的文献,将检索到的文献导入EndNoteX9进行管理.严格按照文献的纳入、排除标准,筛选符合标准的文献,并对其进行质量评价和原始数据提取、整合.最后采用STATA16.0和RevMan5.3软件行Meta分析.结果:最终纳入10篇文献,共计490眼.根据纳入文献的研究类型不同,分别进行原始文献质量评价,纳入文献均为中高质量,且各项研究间基础数据同质性良好.进行Meta分析后发现AGV植入联合玻璃体腔抗VEGF药物注射术后1wk,1mo的眼压较单纯性AGV植入术的有明显下降.且AGV植入术联合玻璃体腔抗VEGF药物注入并不能提高术后BCVA.最后,联合贝伐单抗不会明显提高手术的成功率,但可以显著减少术后仍需使用的抗青光眼药物数量,而雷珠单抗在这两个方面的表现恰恰相反.结论:AGV植入联合玻璃体腔抗VEGF药物注射术治疗NVG,与单纯AGV植入术相比,在降眼压方面存在一定优势,根据抗VEGF药物的不同,对增加手术成功率及减少术后仍需使用的抗青光眼药物数量均有一定积极作用.
- [1]王楠叶,游志鹏,李国栋.内窥镜睫状体光凝术与青光眼阀植入术治疗难治性青光眼的对比研究[J].2017,(6).
- [2]李玥冰,罗鑫,刘太祥,等.Ahmed青光眼引流阀植入术及雷珠单抗治疗新生血管型青光眼的疗效[J].2019,(11).
- [3]兰贤海,张俊莹,马玉胜.引流阀植入及雷珠单抗治疗新生血管性青光眼[J].2019,(6).
- [4]曾明范.两种植入手术治疗难治性青光眼的疗效观察[J].2018,(12).
- [5]黎佳.青光眼阀植入术治疗难治性青光眼的护理体会[J].2016,(6).
- [6]孔繁学,马翔,范松涛,等.玻璃体腔注射雷珠单抗和康柏西普联合青光眼引流阀植入治疗新生血管性青光眼的疗效[J].2017,(6).
- [7]宗良敏,曹二兵.玻璃体腔注射雷珠单抗联合FP-7Ahmed青光眼引流阀植入术治疗新生血管性青光眼的疗效观察[J].2018,(12).
- [8]陈帅征,穆雅林.雷珠单抗联合Ahmed青光眼引流阀植入治疗NVG的Meta分析[J].2020,(11).
- [9]中华医学会眼科学分会青光眼学组.中国新生血管性青光眼诊疗专家共识（2019年）[J].2019,(11).
- [10]刘清洋,马萍萍,梁丽银,等.新生血管性青光眼雷珠单抗玻璃体腔注射术后眼压变化趋势[J].2020,(23).
- [11]Sevim, Mehmet Sahin,Buttanri, Ibrahim Bulent,Kugu, Suleyman,etc.Effect of Intravitreal Bevacizumab Injection before Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma.[J].2013,229(2).
- [12]Arcieri, Enyr S.,Paula, Jayter S.,Jorge, Rodrigo,etc.Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up[J].2015,93(1).
- [13]Chen, Shida,Zhou, Minwen,Wang, Wei,etc.Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes[J].2015,93(7).
- [14]Joyce Mordenti,R. Andrew Cuthbertson,Napoleone Ferrara,etc.Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration[J].1999,27(5).
- [15]Simo R,Wirostko B,Wong TY.Vascular endothelial growth factor and diabetic complications.[J].2008,27(6).
- [16]Tang Min,Fu Yang,Wang Ying,etc.Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma[J].2016,16(1).
- [17].Long-Term Results of Ahmed Glaucoma Valve in Association With Intravitreal Bevacizumab in Neovascular Glaucoma[J].2015,24(5).
- [18]Mahdy,R.A.,Nada,W.M.,Fawzy,K.M.,etc.Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by ahmed valve implantation in neovascular glaucoma[J].2013,22(9).
- [19]Heiduschka P,Fietz H,Hofmeister S,etc.Penetration of bevacizumab through the retina after intravitreal injection in the monkey.[J].2007,48(6).
- [20]田莲姬,崔俊,卢迪,等.玻璃体腔内注射雷珠单抗联合引流阀植入治疗28例新生血管性青光眼的疗效观察[J].2019,(4).